ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Eyenovia Inc

Eyenovia Inc (EYEN)

2.44
-0.23
(-8.61%)
2.49
0.05
(2.05%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.49
Bid
2.49
Ask
2.50
Volume
1,393,873
2.39 Day's Range 3.18
0.85 52 Week Range 124.80
Market Cap
Previous Close
2.67
Open
2.65
Last Trade Time
Financial Volume
$ 3,758,056
VWAP
2.6961
Average Volume (3m)
2,548,014
Shares Outstanding
2,882,808
Dividend Yield
-
PE Ratio
-0.14
Earnings Per Share (EPS)
-17.28
Revenue
57k
Net Profit
-49.82M

About Eyenovia Inc

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precis... Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Eyenovia Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEN. The last closing price for Eyenovia was $2.67. Over the last year, Eyenovia shares have traded in a share price range of $ 0.85 to $ 124.80.

Eyenovia currently has 2,882,808 shares outstanding. The market capitalization of Eyenovia is $7.70 million. Eyenovia has a price to earnings ratio (PE ratio) of -0.14.

EYEN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-41.9580419584.295.882.410195410144.71370035CS
41.36120.3539823011.135.881.0876540972.84816421CS
121.1890.07633587791.315.880.8525480142.8211801CS
26-4.118-62.3184019376.60817.9920.85108201598.26316349CS
52-49.87-95.244461420952.36124.80.85751091811.75950583CS
156-153.51-98.40384615381564680.85279439426.58556862CS
260-244.71-98.9927184466247.2617.60.85179653651.2848341CS

EYEN - Frequently Asked Questions (FAQ)

What is the current Eyenovia share price?
The current share price of Eyenovia is $ 2.49
How many Eyenovia shares are in issue?
Eyenovia has 2,882,808 shares in issue
What is the market cap of Eyenovia?
The market capitalisation of Eyenovia is USD 7.7M
What is the 1 year trading range for Eyenovia share price?
Eyenovia has traded in the range of $ 0.85 to $ 124.80 during the past year
What is the PE ratio of Eyenovia?
The price to earnings ratio of Eyenovia is -0.14
What is the cash to sales ratio of Eyenovia?
The cash to sales ratio of Eyenovia is 122.22
What is the reporting currency for Eyenovia?
Eyenovia reports financial results in USD
What is the latest annual turnover for Eyenovia?
The latest annual turnover of Eyenovia is USD 57k
What is the latest annual profit for Eyenovia?
The latest annual profit of Eyenovia is USD -49.82M
What is the registered address of Eyenovia?
The registered address for Eyenovia is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Eyenovia website address?
The website address for Eyenovia is www.eyenoviabio.com
Which industry sector does Eyenovia operate in?
Eyenovia operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

EYEN Discussion

View Posts
gail gail 5 days ago
huge run now. maybe merger happened?
👍️0
gail gail 6 days ago
rumor of merger news on…..

….

mon or tues, per stocktwits
👍️0
glenn1919 glenn1919 1 week ago
EYEN...........................................https://stockcharts.com/h-sc/ui?s=eyen&p=W&b=5&g=0&id=p86431144783
👍️0
crudeoil24 crudeoil24 1 week ago
June 2 > Form 424B5 - Prospectus [Rule 424(b)(5)]
👍️0
crudeoil24 crudeoil24 1 week ago
Trading float 2.75M shares
👍️0
crudeoil24 crudeoil24 1 week ago
Yearly revenues average $4,790. per employee.
👍️0
gail gail 1 week ago
blasting off! weeee!!!
👍️0
gail gail 1 week ago
yup, holding up great for a friday!
👍️0
Gator44 Gator44 1 week ago
she looks fixin to run
👍️0
gail gail 1 week ago
stocktwits said there may be a…

..

merger of some kind. dont know, dont care, but i like the past chart and how its moving post split.
👍️0
gail gail 1 week ago
it appears someone bought about……




$17mil worth (about 4mil shares) at about $4.40 pre market.
👍️0
gail gail 1 week ago
grabbed some on the dip. hi all.
👍️0
81vette 81vette 1 week ago
Green dragon 🐉 in my dreams
👍️ 2
glenn1919 glenn1919 1 week ago
EYEN....................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
81vette 81vette 1 week ago
Banging out the gate! Up 17% many catalysts inbound
👍️0
81vette 81vette 1 week ago
Looking fantastic again today,Inbound co. Value 44m,zero borrow not even flinching and 242% fee!! Golden atm,merger final will probably be delayed because it’s non- binding but I think a binding one will be enough for run up,this isn’t an in-house scam merger,I see it’s optionable now,looking at calls/puts,they plan on this becoming a huge company,pps is 70% above sma50 so loading has been going on awhile,lots of run room until sma200 makes this an attractive opportunity for investors,especially since the new fins!
👍️0
glenn1919 glenn1919 2 weeks ago
EYEN..................................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
shurtha2000 shurtha2000 2 weeks ago
Going to be a nice run up to Friday
👍️0
81vette 81vette 2 weeks ago
Lowest fill was 1.75
👍️0
81vette 81vette 2 weeks ago
Zero borrow this morning,they not loaning shares to short,I am buying bought 1.85(bids in for more if it drops)
👍️0
glenn1919 glenn1919 2 weeks ago
EYEN.................................................p/m
👍️0
Trev1966 Trev1966 4 weeks ago
Company News Out 5.30 pm Yesterday, Aftert Market Run As Well As Today, GLTA
👍️0
glenn1919 glenn1919 4 weeks ago
EYEN.....................................................................https://stockcharts.com/h-sc/ui?s=eyen&p=W&b=5&g=0&id=p86431144783




longtimenoc
👍️0
Monksdream Monksdream 2 months ago
EYEN under $2
👍️0
Monksdream Monksdream 2 months ago
EYEN, under $2
👍️0
Monksdream Monksdream 2 months ago
EYEN, new 52 week low
👍️0
Monksdream Monksdream 3 months ago
EYEN, new 52 week low
👍️0
Monksdream Monksdream 3 months ago
EYEN, new 52 week low
👍️0
Monksdream Monksdream 3 months ago
EYEN, new 52 week low
👍️0
Monksdream Monksdream 4 months ago
EYEN, new 52 week low

👍️0
Monksdream Monksdream 4 months ago
EYEN , new 52/week low


👍️0
georgie18 georgie18 5 months ago
EYEN...All out with a loss here...🥳

georgie18

Member Level
Re: georgie18 post# 70

Thursday, January 16, 2025 12:26:58 PM

Post#
74
of 74
EYEN...07...🥳...Averaging down on this dip...from my .12 Alert...

georgie18

Member Level
Re: None

Thursday, January 09, 2025 10:29:58 AM

Post#
670925
of 671550
EYEN...12...🥳... https://schrts.co/jpheeDNV ...Open Gap in the .30 range...
👍️0
georgie18 georgie18 5 months ago
EYEN...07...🥳...Averaging down on this dip...from my .12 Alert...

georgie18

Member Level
Re: None

Thursday, January 09, 2025 10:29:58 AM

Post#
670925
of 671550
EYEN...12...🥳... https://schrts.co/jpheeDNV ...Open Gap in the .30 range...
👍 1
tw0122 tw0122 5 months ago


👍️0
tw0122 tw0122 5 months ago
1/6  -- Eyenovia (EYEN) said Monday it is exploring strategic alternatives for its business and has hired Chardan as a financial adviser.
👍️0
tw0122 tw0122 5 months ago

..............,,,,On December 30, 2024, the Company entered into an Amended and Restated Sales Agreement (the “A&R Sales Agreement”) with Chardan Capital Markets, LLC (“Chardan”), as agent, which has been acknowledged and agreed by Leerink Partners LLC (“Leerink Partners”), with respect to the Company’s existing at-the-market offering program with an aggregate offering price of up to $50,000,000 of shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”). The A&R Sales Agreement amends and restates that certain Sales Agreement, dated December 14, 2021, by and between the Company and Leerink Partners (the “Initial Sales Agreement”) to, among other things, replace Leerink Partners with Chardan as sales agent. The Company sold an aggregate of $16,413,443 of shares of Common Stock under the Initial Sales Agreement. The Company will file a prospectus supplement relating to the offer and sale of the Common Stock pursuant to the A&R Sales Agreement, which will form a part of the Company’s Registration Statement on Form S-3 (File No. 333-282458), which was filed with the Securities and Exchange Commission on October 1, 2024 and declared effective on October 8, 2024. Subject to the terms and conditions of the A&R Sales Agreement, Chardan may sell shares of Common Stock by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415(a)(4) of the Securities Act of 1933, as amended (the “Securities Act”). Chardan will use commercially reasonable efforts to sell the Common Stock from time to time, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company will pay Chardan a commission equal to 3.0% of the gross sales proceeds of any Common Stock sold through Chardan under the A&R Sales Agreement. The Company is not obligated to make any sales of Common Stock under the A&R Sales Agreement. The offering of Common Stock will terminate upon the earlier of (i) the sale of all Common Stock subject to the A&R Sales Agreement or (ii) termination of the A&R Sales Agreement in accordance with its terms. The A&R Sales Agreement contains customary representations, warrantees and agreements between the Company and Chardan, including customary indemnification rights, including for liabilities under the Securities Act. The representations, warranties and covenants contained in the A&R Sales Agreement were made only for purposes of such agreement and as of specific dates and were solely for the benefit of the parties to such agreement. The foregoing description of the A&R Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the A&R Sales Agreement, a copy of which is filed as Exhibit 1.1 hereto and is incorporated herein by reference. The legal opinion of Covington & Burling LLP relating to the shares of Common Stock being offered is filed herewith as Exhibit 5.1. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the Common Stock nor shall there be any sale of the Common Stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Item 8.01. Other Events. Termination of Prior ATM Prospectus On December 29, 2024, prior to entry into the A&R Sales Agreement, the Company notified Leerink Partners that it was suspending and terminating the prospectus, dated October 8, 2024, relating to the sale of up to $25,000,000 of Common Stock, that could be issued and sold pursuant to the Initial Sales Agreement. Financial Update As of December 26, 2024, the Company had cash and cash equivalents of $2.2 million. Also as of December 26, 2024, the Company owed $10.1 million in principal and accrued interest under the Loan and Security Agreement, dated November 22, 2022, as amended, with Avenue Capital Management II, L.P., as administrative agent and collateral agent, Avenue Venture Opportunities Fund, L.P., as a lender and Avenue Venture Opportunities Fund II, L.P., as a lender. Item 9.01. Exhibits..... 
👍️0
georgie18 georgie18 5 months ago
EYEN...12...🥳... https://schrts.co/jpheeDNV ...Open Gap in the .30 range...
👍️0
glenn1919 glenn1919 5 months ago
EYEN..................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 months ago
eyen....................................https://stockcharts.com/h-sc/ui?s=eyen&p=W&b=5&g=0&id=p86431144783




onit...............
👍️0
tw0122 tw0122 5 months ago
.30 + 150%
👍️0
tw0122 tw0122 5 months ago
8k keep an eye here 
👍️0
hondaboost hondaboost 7 months ago
Scam: selling 24 Million new shares at $0.10 , just before probable "Bankruptcy"!

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication dispensing platform, today announced that it has entered into a securities purchase agreement with a healthcare focused institutional investor for the purchase and sale of 12,081,785 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 24,163,570 shares of common stock in a registered direct offering at a combined offering price of $0.1076 per share and accompanying warrants. T
👍️0
glenn1919 glenn1919 7 months ago
EYEN..............................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
RC_702 RC_702 8 months ago
And then again, maybe not. You still up 200% or did you sell during that balloon ride
👍️0
saigai saigai 9 months ago
still holding.. see you at trips
👍️0
saigai saigai 9 months ago
just going to hold i dont care anymore im tired of wishing on a star..im better off spending my days with the prayer beads than this nonsense
👍️0
saigai saigai 9 months ago
eyen 3200 at .59 lets gooo
👍️0
rosemountbomber rosemountbomber 10 months ago
Have to agree with you. I was surprised at the size of this offering. Rather not go through this again so will lighten up or liquidate completely on the next strong upward move.
👍️0
ProLiberty ProLiberty 10 months ago
It cost the company a 40% decline and dilution at $0.40 in exchange for 2.5 months of added runway. Not long ago they raised another $5m from 2 investors at $0.62 + warrants (also dilutive). They hope Oct data will allow accelerated approval of Micropine but even if good and accelerated still 12 months from approval. They will still burn and need to raise multiple times between now and 12 months from now. Perhaps they will be able to do it at a higher stock price if the Oct data is good but unclear. To buy today you need to be very confident that Oct data will be excellent.
👍️0
Monksdream Monksdream 10 months ago
EYEN new 52 low
👍️0

Your Recent History

Delayed Upgrade Clock